Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2007
12/13/2007US20070287730 useful for the treatment of HIV and AIDS
12/13/2007US20070287716 Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors
12/13/2007US20070287706 Certain substituted quinolones, compositions, and uses thereof
12/13/2007US20070287699 Antiviral agents
12/13/2007CA2653238A1 Pyrrolidine derivatives useful as bace inhibitors
12/12/2007EP1863765A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents
12/12/2007EP1863757A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/12/2007CN101087760A Crystalline aripiprazole solvates
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN100354263C Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
12/11/2007US7307089 Central nervous system disorders, Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease (enhancement of cognitive memory), sleep disorders, feeding disorders such as anorexia
12/11/2007US7307088 Substituted anthranilic amide derivatives and methods of use
12/11/2007US7307076 Beta agonists for the treatment of respiratory diseases
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007139797A2 Method of preparing 4-halogenated quinoline intermediates
12/06/2007WO2007139496A1 Quinoline derivatives acting as tyrosine kinase inhibitors
12/06/2007WO2007139096A1 Azo dye for anisotropic dye film
12/06/2007WO2007139002A1 Method for producing nitrogen-containing fused ring compound
12/06/2007WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound
12/06/2007WO2007138112A2 Compounds that interact with ion channels, in particular with ion channels from the kv family
12/06/2007WO2007107828A3 Amine derivatives
12/06/2007WO2007072143A3 Chemical compounds
12/06/2007US20070282108 preparing 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone (cilostazol) by reacting 6-hydroxy-3,4-dihydroquinoline-2(1H)-one and 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole in an aqueous single phase
12/06/2007US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007US20070281969 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
12/06/2007US20070281968 Compounds Derived From Artesunate, Preparation Process, Pharmaceutical Composition And Use Of The Respective Medicine
12/06/2007US20070281967 Nuclear Transfer Promoter For Rac Protein And Method Of Screening The Dame
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007US20070281930 bicyclic bisamides for controlling acarina
12/06/2007CA2651448A1 Method of preparing 4-halogenated quinoline intermediates
12/05/2007EP1861401A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
12/05/2007EP1861379A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
12/05/2007EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
12/05/2007EP1860940A1 Biphenyl-n- (4-pyridyl) methylsulfonamides
12/05/2007EP1768973B1 Substituted quinolones
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007CN101081834A Process for the preparation of leukotriene antagonists
12/05/2007CN100352815C Phosphorescence compound and electro field light emitting device having the same
12/04/2007US7304174 CaSR antagonist
12/04/2007US7304168 For tracing/imaging molecular transfer between cellular gap junctions
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007WO2007136125A1 Compound having heterocyclic ring and use thereof
11/29/2007WO2007136103A1 Antitumor agent for thyroid cancer
11/29/2007WO2007135565A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/29/2007WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007WO2007134537A1 Organic compounds containing heteroatoms and their use in ziegler-natta catalyst with single activation center
11/29/2007WO2007106537A3 Aminoquinolones as gsk-3 inhibitors
11/29/2007WO2007100366A3 Quinolone m1 receptor positive allosteric modulators
11/29/2007WO2007045893A3 Beta adrenergic receptor pharmacophore
11/29/2007WO2007017144A3 Macrocylic inhibitors of hepatitis c virus
11/29/2007US20070276168 Method For Preparation Of A Fluoroaromatic Compound From An Aminoaromatic Compound
11/29/2007US20070276140 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070275980 Amide Derivatives, Process For Preparation Thereof And Use Thereof As Insecticide
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007US20070275909 Useful in the treatment and prevention of atherosclerosis and for the reduction of cholesterol levels; carbohydrate-containing pyrazolidinone or oxazolidinone derivatives, for example
11/29/2007US20070274922 such as 2-((methylamino)methyl)quinoline-8-yl-boronic acid
11/29/2007US20070271730 Magnet for loose friction checks to rods including those of basic door closers
11/29/2007CA2652442A1 Antitumor agent for thyroid cancer
11/29/2007CA2650795A1 Novel microbiocides
11/29/2007CA2649224A1 Thiazolidinedione derivatives as pi3 kinase inhibitors
11/28/2007EP1860104A1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858855A1 Process of making crystalline type ii aripiprazole
11/28/2007EP1858513A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
11/28/2007EP1667975B1 A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
11/28/2007EP1654225A4 Melanin concentrating hormone receptor antagonists
11/28/2007EP1307429B1 Process for asymmetric synthesis of substituted 1,4-dihydropyridines
11/28/2007CN101080393A New (5's)-2',4'-dicyclopentyl -3'-9(s)-fluoro(4-(trifluoromethyl) phenyl)methyl)-5',8' -dihydro-6'h-spiro(cyclopropane-1,7'-quinoline)- 5'-ol is a cholesterol ester transfer protein inhibitor useful f
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/27/2007US7301024 Crystalline forms of gatifloxacin and processes for preparation
11/27/2007US7301021 Substituted imidazole compounds
11/27/2007US7300954 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300910 superior soot dispersion
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/27/2007CA2264097C Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132482A2 Novel process for the preparation of pitavastatin and its pharmaceutically acceptable salts
11/22/2007WO2007131350A1 Inhibitors of human immunodeficiency virus replication
11/22/2007US20070270463 such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-quinol-6-ylmethylsulfonamide; azeotropic distillation, crystallization; central nervous system disorders
11/22/2007US20070270461 Fungicide
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270312 Heteroaroyl-Substituted Serineamides
11/22/2007CA2650798A1 Inhibitors of human immunodeficiency virus replication
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators
11/21/2007EP1856077A1 Piperazine derivatives as glyt1 inhibitors
11/21/2007EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007EP1563852B1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 277